71 results
8-K
EX-10.1
COGT
Cogent Biosciences Inc
22 Mar 24
Unregistered Sales of Equity Securities
8:33am
, assessment, arbitration or inquiry, or any proceeding or, to the Stockholder’s knowledge, investigation, by or before any governmental authority
8-K
EX-10.2
eazpa8m445nrz60bws
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
424B5
e7et9nuw0p51xvi8kb
8 Jun 23
Prospectus supplement for primary offering
4:01pm
424B5
t8n1zmp0 4l
6 Jun 23
Prospectus supplement for primary offering
5:22pm
8-K
EX-99.2
qo1ook 620c
12 Dec 22
Cogent Biosciences Announces Positive Updated Clinical Data from Ongoing Phase 2 APEX Trial Evaluating
8:03am
8-K
EX-99.1
o2cp1m5hzs9gp7e0
12 Dec 22
Cogent Biosciences Announces Positive Updated Clinical Data from Ongoing Phase 2 APEX Trial Evaluating
8:03am
8-K
EX-99.1
fr2qnte3q1kghfpzbr
14 Nov 22
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2022 Financial Results
7:14am
424B5
b29a5hs
15 Jun 22
Prospectus supplement for primary offering
5:16pm
424B5
nfp9e vmt
13 Jun 22
Prospectus supplement for primary offering
6:11am
8-K
EX-99.1
cgriks2z acw1x92n
10 Jun 22
Submission of Matters to a Vote of Security Holders
7:12am